| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/21/2011 | US20110178027 Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents |
| 07/21/2011 | US20110178025 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 07/21/2011 | US20110178024 Amyloid beta-peptides and methods of use thereof |
| 07/21/2011 | US20110178022 Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction |
| 07/21/2011 | US20110178021 Opiorphin for use as a psychostimulant agent |
| 07/21/2011 | US20110178013 Novel octapeptide compounds derived from somatostatin and the therapeutic use thereof |
| 07/21/2011 | US20110178010 Use of peptides for promoting wound healing |
| 07/21/2011 | US20110178003 Optimized dengue virus entry inhibitory peptide (10an) |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177109 Antigenic tau peptides and uses thereof |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177080 Novel p2x7 epitopes |
| 07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | CA2785185A1 Organic compounds for the regulation of vectorial ion channels |
| 07/20/2011 | EP2344522A1 Combination adjuvant formulation |
| 07/20/2011 | EP2344521A2 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 07/20/2011 | EP2344520A2 Inhibiting interaction between hif-1a and p300/cbp with hydrogen bond surrogate-based helices |
| 07/20/2011 | EP2344519A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
| 07/20/2011 | EP2344178A1 Peptide sequences, their branched form and use thereof for antimicrobial applications |
| 07/20/2011 | EP2160221B1 Cyclic peptide cxcr4 antagonists |
| 07/20/2011 | EP1496930B1 G-type peptides to ameliorate atherosclerosis |
| 07/20/2011 | EP1458748B1 Apoptotically active peptides |
| 07/20/2011 | CN1781933B Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |
| 07/20/2011 | CN102131926A Transfection agent |
| 07/20/2011 | CN102127155A Preparation of somatostatin peptides |
| 07/20/2011 | CN102127154A A54-GFLG-DOX conjugate as well as coupling method and application thereof |
| 07/20/2011 | CN102127153A Caco-2 cell surface specific binding polypeptide and screening method thereof |
| 07/20/2011 | CN102127152A Antagonistic peptide of anti-opioid peptide and application thereof |
| 07/20/2011 | CN102127151A Antagonistic peptide of anti-opioid peptide and application thereof |
| 07/20/2011 | CN102127150A Nestin portion polypeptide and application thereof |
| 07/20/2011 | CN102127149A Myocardial specificity homeobox part polypeptide and application thereof |
| 07/20/2011 | CN102127148A Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
| 07/20/2011 | CN102127147A Mimotope of epidermal growth factor receptor (EGFR) and use thereof |
| 07/20/2011 | CN102127146A Method for preparing atosiban acetate |
| 07/20/2011 | CN102127145A Substituted tetrahydroisoquinoline compound as well as preparation method and application thereof |
| 07/20/2011 | CN101648992B Small peptide B with antibacterial and antitumor functions and applications thereof |
| 07/20/2011 | CN101638432B Rana pleuraden antioxidant peptide and genes |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981998 Bis-sulfhydryl macrocyclization systems |
| 07/19/2011 | CA2565195C Antimicrobial polypeptides |
| 07/19/2011 | CA2448169C Peptides and the use thereof in darkening the skin |
| 07/19/2011 | CA2336445C Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/19/2011 | CA2185656C Protein tyrosine kinase agonist antibodies |
| 07/14/2011 | WO2011084685A2 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | WO2011084604A2 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 07/14/2011 | WO2011084571A2 Azide derivatives for phototherapy |
| 07/14/2011 | WO2011083296A1 T cell clonotypes |
| 07/14/2011 | WO2011031460A3 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 07/14/2011 | WO2011028507A3 Compositions, methods, and kits for determining an alkyl transferase |
| 07/14/2011 | US20110172164 Bi-dentate compounds as kinase inhibitors |
| 07/14/2011 | US20110172163 Novel Protease Inhibitors |
| 07/14/2011 | US20110172157 Somatostatin analogues |
| 07/14/2011 | US20110172155 Beta thymosin fragments |
| 07/14/2011 | US20110172153 Screening methods using g-protein coupled receptors and related compositions |
| 07/14/2011 | US20110172147 Neuropeptide-2 receptor (y-2r) agonists |
| 07/14/2011 | US20110172139 Peptides whose uptake by cells is controllable |
| 07/14/2011 | US20110171304 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus |
| 07/14/2011 | US20110171259 Novel Compositions and Adjuvants |
| 07/14/2011 | US20110171245 Recombinant antigen for diagnosis and prevention of murine typhus |
| 07/14/2011 | US20110171243 Compounds for treating amyloidoses |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171223 Anti-peptide antibodies that cross react with protective antigen of bacillus anthracis and uses thereof |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171169 Peptides for active anti-cytokine immunization |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171122 Methods and compositions for the detection of cancer |
| 07/14/2011 | CA2822026A1 Saposin-a derived peptides and uses thereof |
| 07/13/2011 | EP2343551A1 Disheveled PDZ modulators |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343311A2 Peptide inhibitors of HK2 and their use |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2342220A1 Methods and systems for predicting misfolded protein epitopes |
| 07/13/2011 | EP2342214A1 Peptidomimetic macrocycles |
| 07/13/2011 | EP2342213A1 Antimicrobial peptides |
| 07/13/2011 | EP2341921A1 Antimicrobial peptides |
| 07/13/2011 | EP2341920A1 Antimicrobial peptides |
| 07/13/2011 | EP1812466B1 Compositions and methods for the control of mammary cell number |
| 07/13/2011 | EP1718670B1 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonist/antagonist activity |
| 07/13/2011 | EP1714976B1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/13/2011 | EP1377602B1 Use of organosiloxane polysulphides in dienic elastomers compositions |
| 07/13/2011 | EP1281323B1 Compositions containing peptide and electrolyte excretion promoter and foods containing the same |
| 07/13/2011 | CN102124023A Peptide des-[asp1]-[ala1], angiotensin-(1-7) agonist and pharmaceutical compounds for the treatment of diseases |
| 07/13/2011 | CN102124022A Use of a tpb salt for the separation of biomolecules |
| 07/13/2011 | CN102124021A Peptide manufacturing process |
| 07/13/2011 | CN102120758A Mycobacterium tuberculosis antibody binding peptide and application thereof |
| 07/13/2011 | CN102120757A Hybrid peptide using 3S-tetrahydro-beta-carboline-3-carboxylic acid as connecting arm, and preparation method and application thereof |
| 07/13/2011 | CN102120756A Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof |
| 07/13/2011 | CN102120755A Brown adipose tissue targeted polypeptide and applications thereof |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977307 Method for reducing pain with ziconotide and morphine |
| 07/12/2011 | US7977304 FK 228 derivates as HDAC inhibitors |
| 07/12/2011 | US7977068 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/12/2011 | CA2486738C Method for identifying immunoreactive peptides |
| 07/12/2011 | CA2440610C Induction of tumor immunity by variants of folate binding protein |